Clinical Trial: A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study

U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375979) titled 'A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study' on Jan. 21.

Brief Summary: This study is a multi-center, observational study aiming to develop an early screening multi-model for detecting lung cancer signals through the integration of imaging (non-contrast CT) and blood testing (cfDNA methylation).

Study Start Date: Feb. 05

Study Type: OBSERVATIONAL

Condition: Lung Cancer

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Information provided by (Responsible Party): Chang Chen, Shanghai Pul...